The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Prognostic and predictive factors in colorectal cancer
Abstract
Prognostication of newly diagnosed colorectal cancer (CRC) predominantly relies on stage as defined by the UICC-TNM and American Joint Committee on Cancer classifications. Tumour extent, lymph node status, tumour grade and the assessment of lymphatic and venous invasion are still the most important morphological prognostic factors. Evidence suggests that tumour budding and tumour border configuration are important, additional histological parameters but are not regarded as essential in prognosis. Although several molecular features, such as LOH18q and TP53 mutation analysis, have shown promising results in terms of their prognostic value, the American Society of Clinical Oncology Tumor Markers Expert Panel does not currently recommend their use in routine practice. cDNA-microarray, PCR and fluorescence in situ hybridisation are now frequently used to identity potential prognostic indicators in CRC, but the applicability of these methods in routine use is likely to have limited impact. Reliable prognostic markers identified by immunohistochemical protein profiling have yet to be established. Randomisation of data sets, assessment of interobserver variability for protein markers and scoring systems, as well as the use of receiver operating characteristic curve analysis in combination with multimarker-phenotype analysis of several different markers may be an effective tactical approach to increase the value of immunohistochemical findings. This article reviews the well established and additional prognostic factors in CRC and explores the contribution of molecular studies to the prognostication of patients with this disease. Additionally, an approach to improve the prognostic value of immunohistochemical protein markers is proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Leman, E. S., Schoen, R. E., Weissfeld, J. L., Cannon, G. W., Sokoll, L. J., Chan, D. W., & Getzenberg, R. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0649 · Cited by 51
RetractedClassification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 20,825
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Classification and regression trees
Praagman, J. (1985) · European Journal of Operational Research · doi:10.1016/0377-2217(85)90321-2 · Cited by 10,053
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
TNM Classification of Malignant Tumours
(2003) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471463752 · Cited by 3,946
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging
O'Connell, J. B., Maggard, M. A., & Ko, C. Y. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh275 · Cited by 1,599
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
Locker, G. Y., Hamilton, S., Harris, J., Jessup, J. M., Kemeny, N., Macdonald, J. S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2644 · Cited by 1,592
Benson, A. B., Schrag, D., Somerfield, M. R., Cohen, A. M., Figueredo, A. T., Flynn, P. J., Krzyzanowska, M. K., Maroun, J., McAllister, P., Van Cutsem, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.063 · Cited by 1,430
Review of epidermal growth factor receptor biology
Herbst, R. S. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.11.041 · Cited by 1,390
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,343
Prognostic Factors in Prostate Cancer: College of American Pathologists Consensus Statement 1999
Bostwick, D. G., Grignon, D. J., Hammond, M. E. H., Amin, M. B., Cohen, M., Crawford, D., Gospadarowicz, M., Kaplan, R. S., Miller, D. S., Montironi, R., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0995-pfipc · Cited by 1,239
Prognostic Factors in Colorectal Cancer: College of American Pathologists Consensus Statement 1999
Compton, C. C., Fielding, L. P., Burgart, L. J., Conley, B., Cooper, H. S., Hamilton, S. R., Hammond, M. E. H., Henson, D. E., Hutter, R. V. P., Nagle, R. B., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0979-pficc · Cited by 1,230
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
Ferrara, N., Hillan, K. J., & Novotny, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.132 · Cited by 977
Statistics review 13: receiver operating characteristic curves.
Bewick, V., Cheek, L., & Ball, J. (2004) · Critical Care · doi:10.1186/cc3000 · Cited by 818
Kim, H., Jen, J., Vogelstein, B., & Hamilton, S. R. (1994) · PubMed Central · Cited by 809
Risk factors for an adverse outcome in early invasive colorectal carcinoma
Ueno, H., Mochizuki, H., Hashiguchi, Y., Shimazaki, H., Aida, S., Hase, K., Matsukuma, S., Kanai, T., Kurihara, H., Ozawa, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.022 · Cited by 758
A NEW PROGNOSTIC CLASSIFICATION OF RECTAL CANCER
Jass, J. R., Love, S. B., & Northover, J. M. A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90552-6 · Cited by 701
Tumour `budding' as an index to estimate the potential of aggressiveness in rectal cancer
Ueno, H., Murphy, J., Jass, J. R., Mochizuki, H., & Talbot, I. C. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01324.x · Cited by 655
Jain, R. K., Tong, R. T., & Munn, L. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4102 · Cited by 612
Vascular endothelial growth factor (VEGF) signaling in tumor progression
Roskoski, R. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.01.006 · Cited by 599
American Joint Committee on Cancer prognostic factors consensus conference: Colorectal working group
Compton, C., Fenoglio-Preiser, C. M., Pettigrew, N., & Fielding, L. P. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000401)88:7<1739::aid-cncr30>3.0.co;2-t · Cited by 599
Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective
Kowanetz, M., & Ferrara, N. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1520 · Cited by 564
The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases
JASS, J. R., ATKIN, W. S., CUZICK, J., BUSSEY, H. J. R., MORSON, B. C., NORTHOVER, J. M. A., & TODD, I. P. (1986) · Histopathology · doi:10.1111/j.1365-2559.1986.tb02497.x · Cited by 538
Prognostic value of tumor “budding” in patients with colorectal cancer
Hase, K., Shatney, C., Johnson, D., Trollope, M., & Vierra, M. (1993) · Diseases of the Colon & Rectum · doi:10.1007/bf02238588 · Cited by 536
Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma
Smyrk, T. C., Watson, P., Kaul, K., & Lynch, H. T. (2001) · Cancer · doi:10.1002/1097-0142(20010615)91:12<2417::aid-cncr1276>3.0.co;2-u · Cited by 522
Histopathological Identification of Colon Cancer with Microsatellite Instability
Alexander, J., Watanabe, T., Wu, T.-T., Rashid, A., Li, S., & Hamilton, S. R. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63994-6 · Cited by 511
Duffy, M. J., van Dalen, A., Haglund, C., Hansson, L., Holinski-Feder, E., Klapdor, R., Lamerz, R., Peltomaki, P., Sturgeon, C., & Topolcan, O. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.03.021 · Cited by 506
Clinical Trial Designs for Predictive Marker Validation in Cancer Treatment Trials
Sargent, D. J., Conley, B. A., Allegra, C., & Collette, L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.112 · Cited by 499
Dolcetti, R., Viel, A., Doglioni, C., Russo, A., Guidoboni, M., Capozzi, E., Vecchiato, N., Macrì, E., Fornasarig, M., & Boiocchi, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65436-3 · Cited by 480
Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer
Carethers, J. M., Smith, E. J., Behling, C. A., Nguyen, L., Tajima, A., Doctolero, R. T., Cabrera, B. L., Goel, A., Arnold, C. A., Miyai, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.023 · Cited by 471
Morphology of sporadic colorectal cancer with DNA replication errors
Jass, J. R., Do, K.-A., Simms, L. A., Iino, H., Wynter, C., Pillay, S. P., Searle, J., Radford-Smith, G., Young, J., & Leggett, B. (1998) · Gut · doi:10.1136/gut.42.5.673 · Cited by 466
Impact of EGFR expression on colorectal cancer patient prognosis and survival
Spano, J.-P., Lagorce, C., Atlan, D., Milano, G., Domont, J., Benamouzig, R., Attar, A., Benichou, J., Martin, A., Morere, J.-F., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi006 · Cited by 462
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer.
Ohtani, H. (2007) · PubMed · Cited by 436
Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular Features
Compton, C. C. (2003) · Modern Pathology · doi:10.1097/01.mp.0000062859.46942.93 · Cited by 403
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
Ropponen, K. M., Eskelinen, M. J., Lipponen, P. K., Alhava, E., & Kosma, V.-M. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199707)182:3<318::aid-path862>3.0.co;2-6 · Cited by 398
Microsatellite instability and the clinicopathological features of sporadic colorectal cancer
Ward, R., Meagher, A., Tomlinson, I., O'Connor, T., Norrie, M., Wu, R., & Hawkins, N. (2001) · Gut · doi:10.1136/gut.48.6.821 · Cited by 384
Microsatellite instability and colorectal cancer prognosis
Benatti, P., Gafà, R., Barana, D., Marino, M., Scarselli, A., Pedroni, M., Maestri, I., Guerzoni, L., Roncucci, L., Menigatti, M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1030 · Cited by 379
Jenkins, M. A., Hayashi, S., O’Shea, A.-M., Burgart, L. J., Smyrk, T. C., Shimizu, D., Waring, P. M., Ruszkiewicz, A. R., Pollett, A. F., Redston, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.044 · Cited by 373
Tumour budding in colorectal carcinoma
Prall, F. (2007) · Histopathology · doi:10.1111/j.1365-2559.2006.02551.x · Cited by 369
Molecular Staging for Survival Prediction of Colorectal Cancer Patients
Eschrich, S., Yang, I., Bloom, G., Kwong, K. Y., Boulware, D., Cantor, A., Coppola, D., Kruhøffer, M., Aaltonen, L., Orntoft, T. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.695 · Cited by 348
Ghadimi, B. M., Grade, M., Difilippantonio, M. J., Varma, S., Simon, R., Montagna, C., Füzesi, L., Langer, C., Becker, H., Liersch, T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.406 · Cited by 348
Guidoboni, M., Gafà, R., Viel, A., Doglioni, C., Russo, A., Santini, A., Del Tin, L., Macrì, E., Lanza, G., Boiocchi, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61695-1 · Cited by 322
Atkins, D., Reiffen, K.-A., Tegtmeier, C. L., Winther, H., Bonato, M. S., & Störkel, S. (2004) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.3a6195.2004 · Cited by 319
The DCC Protein and Prognosis in Colorectal Cancer
Shibata, D., Reale, M. A., Lavin, P., Silverman, M., Fearon, E. R., Steele, G., Jessup, J. M., Loda, M., & Summerhayes, I. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612053352303 · Cited by 308
P53 abnormalities and outcomes in colorectal cancer: a systematic review
Munro, A. J., Lain, S., & Lane, D. P. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602358 · Cited by 289
Allegra, C. J., Paik, S., Colangelo, L. H., Parr, A. L., Kirsch, I., Kim, G., Klein, P., Johnston, P. G., Wolmark, N., & Wieand, H. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.044 · Cited by 282
Greenson, J. K., Bonner, J. D., Ben-Yzhak, O., Cohen, H. I., Miselevich, I., Resnick, M. B., Trougouboff, P., Tomsho, L. D., Kim, E., Low, M., et al. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200305000-00001 · Cited by 252
Reduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer
Malesci, A., Laghi, L., Bianchi, P., Delconte, G., Randolph, A., Torri, V., Carnaghi, C., Doci, R., Rosati, R., Montorsi, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0366 · Cited by 245
Morodomi, T., Isomoto, H., Shirouzu, K., Kakegawa, K., Irie, K., & Morimatsu, M. (1989) · Cancer · doi:10.1002/1097-0142(19890201)63:3<539::aid-cncr2820630323>3.0.co;2-s · Cited by 241
Jover, R., Zapater, P., Castells, A., Llor, X., Andreu, M., Cubiella, J., Piñol, V, Xicola, R. M., Bujanda, L., Reñé, J. M., et al. (2006) · Gut · doi:10.1136/gut.2005.073015 · Cited by 228
Zlobec, I., Steele, R., Terracciano, L., Jass, J. R., & Lugli, A. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.044537 · Cited by 225
Self-citationSporadic colorectal adenocarcinomas with high‐frequency microsatellite instability
Gafà, R., Maestri, I., Matteuzzi, M., Santini, A., Ferretti, S., Cavazzini, L., & Lanza, G. (2000) · Cancer · doi:10.1002/1097-0142(20001115)89:10<2025::aid-cncr1>3.3.co;2-j · Cited by 216
FDA Drug Approval Summary: Panitumumab (Vectibix™)
Giusti, R. M., Shastri, K. A., Cohen, M. H., Keegan, P., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-5-577 · Cited by 214
Tissue microarrays in drug discovery
Sauter, G., Simon, R., & Hillan, K. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1254 · Cited by 194
Resnick, M. B., Routhier, J., Konkin, T., Sabo, E., & Pricolo, V. E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0462 · Cited by 192
Popat, S., & Houlston, R. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.039 · Cited by 187
Compton, C. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-384a-pfic · Cited by 185
The future of the TNM staging system in colorectal cancer: time for a debate?
Quirke, P., Williams, G. T., Ectors, N., Ensari, A., Piard, F., & Nagtegaal, I. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70205-x · Cited by 173
Sturm, I., Köhne, C.-H., Wolff, G., Petrowsky, H., Hillebrand, T., Hauptmann, S., Lorenz, M., Dörken, B., & Daniel, P. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1364 · Cited by 173
Khorana, A. A., Ryan, C., Cox, C., Eberly, S. W., & Sahasrabudhe, D. M. (2003) · Cancer · doi:10.1002/cncr.11152 · Cited by 170
Curran, S., Dundas, S. R., Buxton, J., Leeman, M. F., Ramsay, R., & Murray, G. I. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0424 · Cited by 168
Lugli, A., Zlobec, I., Minoo, P., Baker, K., Tornillo, L., Terracciano, L., & Jass, J. R. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02620.x · Cited by 154
Self-citationGiralt, J., Heras, M. D. L., Cerezo, L., Eraso, A., Hermosilla, E., Velez, D., Luján, J., Espín, E., Rosselló-Urgell, J., Majó, J., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.12.021 · Cited by 144
Zlobec, I., Lugli, A., Baker, K., Roth, S., Minoo, P., Hayashi, S., Terracciano, L., & Jass, J. R. (2007) · The Journal of Pathology · doi:10.1002/path.2164 · Cited by 143
Self-citationKim, I.-J., Lim, S., Kang, H. C., Chang, H. J., Ahn, S.-A., Park, H., Jang, S., Park, J.-H., Kim, D. Y., Jung, K. H., et al. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-277-7 · Cited by 137
Galizia, G., Lieto, E., Ferraraccio, F., Vita, F. D., Castellano, P., Orditura, M., Imperatore, V., Mura, A. L., Manna, G. L., Pinto, M., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.052 · Cited by 137
Minoo, P., Zlobec, I., Baker, K., Tornillo, L., Terracciano, L., Jass, J. R., & Lugli, A. (2007) · American Journal of Clinical Pathology · doi:10.1309/5d7mm22davgdt1r8 · Cited by 130
Self-citationProfiling markers of prognosis in colorectal cancer.
Lyall, M. S., Dundas, S. R., Curran, S., & Murray, G. I. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1864 · Cited by 122
Xie, W. Q., Rimm, D. L., Lin, Y., Shih, W. J., & Reiß, M. (2003) · The Cancer Journal · doi:10.1097/00130404-200307000-00013 · Cited by 121
Optimal Pathologic Staging: Defining Stage II Disease
Compton, C. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1398 · Cited by 111
Molecular heterogeneity of colorectal cancer: Implications for cancer control
Jass, J. R. (2007) · Surgical Oncology · doi:10.1016/j.suronc.2007.10.039 · Cited by 107
Willett, C. G., Kozin, S. V., Duda, D. G., di Tomaso, E., Kozak, K. R., Boucher, Y., & Jain, R. K. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.08.007 · Cited by 100
Knösel, T., Emde, A., Schlüns, K., Chen, Y., Jürchott, K., Krause, M., Dietel, M., & Petersen, I. (2005) · Neoplasia · doi:10.1593/neo.05178 · Cited by 96
Evolution of colorectal cancer: Change of pace and change of direction
Jass, J. R., Young, J. P., & Leggett, B. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02635.x · Cited by 95
Nakamura, T., Mitomi, H., Kikuchi, S., Ohtani, Y., & Sato, K. (2005) · PubMed · Cited by 92
Zlobec, I., Steele, R. J., Michel, R. P., Compton, C. C., Lugli, A., & Jass, J. R. (2006) · Modern Pathology · doi:10.1038/modpathol.3800642 · Cited by 87
Self-citationAngiogenesis in Colorectal Cancer: Prognostic and Therapeutic Implications
Giatromanolaki, A. N., Sivridis, E., & Koukourakis, M. I. (2006) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000221317.56731.4e · Cited by 85
Nehls, O., Okech, T., Hsieh, C., Enzinger, T., Sarbia, M., Borchard, F., Gruenagel, H. H., Gaco, V., Hass, H. G., Arkenau, H., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603728 · Cited by 80
Molecular prognostic factors in rectal cancer treated by radiation and surgery
Qiu, H., Sirivongs, P., Rothenberger, M. K., Rothenberger, D. A., & García‐Aguilar, J. (2000) · Diseases of the Colon & Rectum · doi:10.1007/bf02237186 · Cited by 78
Knösel, T., Emde, V., Schlüns, K., Schlag, P. M., Dietel, M., & Petersen, I. (2006) · Analytical Cellular Pathology · doi:10.1155/2006/354295 · Cited by 74
Zlobec, I., Vuong, T., Compton, C. C., Lugli, A., Michel, R. P., Hayashi, S., & Jass, J. R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604172 · Cited by 74
Self-citationZlobec, I., Baker, K., Minoo, P., Jass, J. R., Terracciano, L., & Lugli, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1380 · Cited by 72
Self-citationZlobec, I., Minoo, P., Baker, K., Haegert, D. G., Khetani, K., Tornillo, L., Terracciano, L., Jass, J. R., & Lugli, A. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.01.029 · Cited by 68
Self-citationZlobec, I., Vuong, T., Hayashi, S., Haegert, D. G., Tornillo, L., Terracciano, L., Lugli, A., & Jass, J. R. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603619 · Cited by 68
Self-citationHoos, A., Nissan, A., Stojadinovic, A., Shia, J., Hedvat, C. V., Leung, D. H. Y., Paty, P. B., Klimstra, D. S., Cordon‐Cardo, C., & Wong, W. D. (2002) · PubMed · Cited by 65
Baker, K., Zlobec, I., Tornillo, L., Terracciano, L., Jass, J. R., & Lugli, A. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.11.012 · Cited by 64
Self-citationPrall, F., & Ostwald, C. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.04.002 · Cited by 62
Sun, X., Rütten, S., Zhang, H., & Nordenskjöld, B. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1745 · Cited by 62
Zlobec, I., Minoo, P., Baumhoer, D., Baker, K., Terracciano, L., Jass, J. R., & Lugli, A. (2007) · Cancer · doi:10.1002/cncr.23208 · Cited by 61
Self-citationAzria, D., Bibeau, F., Barbier, N., Zouhair, A., Lemanski, C., Rouanet, P., Ychou, M., Sénesse, P., Özşahin, M., Pèlegrin, A., et al. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-62 · Cited by 58
Lugli, A., Zlobec, I., Günthert, U., Minoo, P., Baker, K., Tornillo, L., Terracciano, L., & Jass, J. R. (2006) · Modern Pathology · doi:10.1038/modpathol.3800648 · Cited by 56
Self-citationZlobec, I., Steele, R. J., Nigam, N., & Compton, C. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2587 · Cited by 50
Self-citationLin, L.-C., Lee, H.-H., Hwang, W.-S., Li, C., Huang, C., Que, J., Lin, K.-L., Lin, F., & Lu, C. (2006) · Surgical Oncology · doi:10.1016/j.suronc.2007.01.001 · Cited by 46
Newer Pathologic Assessment Techniques for Colorectal Carcinoma
Turner, R. R., Li, C., & Compton, C. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1151 · Cited by 46
Molecular responses of rectal cancer to preoperative chemoradiation
Debucquoy, A., Goethals, L., Geboes, K., Roels, S., Bride, W. H. M., & Haustermans, K. M. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.07.016 · Cited by 44
Pathology of Colorectal Cancer
Treanor, D. E., & Quirke, P. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.08.012 · Cited by 44
Rosati, G., Chiacchio, R., Reggiardo, G., Sanctis, D. D., & Manzione, L. (2004) · Tumor Biology · doi:10.1159/000081389 · Cited by 43
Valera, V., Walter, B. A., Yokoyama, N., Koyama, Y., Iiai, T., 岡本, 春., & Hatakeyama, K. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9145-2 · Cited by 43
Giralt, J., Navalpotro, B., Hermosilla, E., de Torres, I. M., Espín, E., Reyes, V., Cerezo, L., Heras, M. D. L., y Cajal, S. R., Armengol, M., et al. (2006) · Oncology · doi:10.1159/000107105 · Cited by 42
The Potential Role of TGFβ1, TGFβ2 and TGFβ3 Protein Expression in Colorectal Carcinomas
Tsamandas, A. C., Kardamakis, D. M., Ravazoula, P., Zolota, V., Salakou, S., Tepetes, K., Kalogeropoulou, C., Tsota, I., Kourelis, T., Makatsoris, T., et al. (2004) · Strahlentherapie und Onkologie · doi:10.1007/s00066-004-1149-x · Cited by 38
Elkablawy, M. A., Maxwell, P., Williamson, K. E., Anderson, N., & Hamilton, P. W. (2001) · The Journal of Pathology · doi:10.1002/path.894 · Cited by 37
Cutsem, E. V., & Kataja, V. V. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi808 · Cited by 36
DCC protein as a predictor of distant metastases after curative surgery for rectal cancer
Reymond, M. A., Dworak, O., Remke, S., Hohenberger, W., Kirchner, T., & Köckerling, F. (1998) · Diseases of the Colon & Rectum · doi:10.1007/bf02236264 · Cited by 35
Ojima, E., Inoue, Y., Miki, C., Mori, M., & Kusunoki, M. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2089-x · Cited by 30
Bendardaf, R., Lamlum, H., ki, R. R. A., Korkeila, E. A., nen, K. S., & Pyrhönen, S. O. (2007) · Tumor Biology · doi:10.1159/000107417 · Cited by 27
Mitomi, H., Mori, A., Kanazawa, H., Nishiyama, Y., Ihara, A., Otani, Y., Sada, M., Kobayashi, K., & Igarashi, M. (2005) · PubMed · Cited by 27
Tornillo, L., Lugli, A., Zlobec, I., Willi, N., Glatz, K., Lehmann, F. S., Spichtin, H., Maurer, R. E., Stoios, D., Sauter, G., et al. (2007) · American Journal of Clinical Pathology · doi:10.1309/6rt941w1g6gdehue · Cited by 25
Self-citationAschele, C., Debernardis, D., Lonardi, S., Bandelloni, R., Casazza, S., Monfardini, S., & Gallo, L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.066 · Cited by 25
Peng, J.-J., Cai, S.-J., Lu, H.-F., Cai, G.-X., Lian, P., Guan, Z.-Q., Wang, M.-H., & Xu, Y. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i21.3009 · Cited by 24
Cited by
Ying, H.-Q., Deng, Q.-W., He, B.-S., Pan, Y.-Q., Wang, F., Sun, H.-L., Chen, J., Liu, X., & Wang, S.-K. (2014) · Medical Oncology · doi:10.1007/s12032-014-0305-0 · Cited by 317
van Krieken, J. H. J. M., Jung, A., Kirchner, T., Carneiro, F., Seruca, R., Bosman, F. T., Quirke, P., Fléjou, J. F., Plato Hansen, T., de Hertogh, G., et al. (2008) · Virchows Archiv · doi:10.1007/s00428-008-0665-y · Cited by 289
Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
Roth, A. D., Delorenzi, M., Tejpar, S., Yan, P., Klingbiel, D., Fiocca, R., d'Ario, G., Cisar, L., Labianca, R., Cunningham, D., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs427 · Cited by 284
Plasma MiR-21: A Potential Diagnostic Marker of Colorectal Cancer
Kanaan, Z., Rai, S. N., Eichenberger, M. R., Roberts, H., Keskey, B., Pan, J., & Galandiuk, S. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e318265bd6f · Cited by 269
Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer
Coppedè, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i4.943 · Cited by 264
Metadata
- Authors
- Zlobec, I., & Lugli, A.
- Venue
- Postgraduate Medical Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-08-01
- Volume
- 84
- Issue
- 994
- Pages
- 403-411
- ISSN
- 0032-5473 (ISSN-L)
- 1469-0756
- OpenAlex
- W2741178274
- Cited by
- 280
- References
- 119
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.